Concepedia

Author

A. Nigel Brooks

AstraZeneca (United Kingdom)

Also Known As

A. Nigel Brooks, Anthony Nigel Brooks

23

Publications

759

Citations

6

H-Index

17

Concepts

All Affiliations

AstraZeneca (United Kingdom)
AN

About

A. Nigel Brooks is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

556

2

Pharmacology

3

3

556

3

Health Sciences

1

1

14

4

Cell Biology

1

1

491

5

Cancer Therapeutics

1

1

14

A. Nigel Brooks

×

6

Publications

757

Citations

6

H-Index

YearCitations

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

Paul R. Gavine, Lorraine Mooney, Elaine Kilgour,

Cancer Research

2012

491

Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i> -Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models

Jingchuan Zhang, Lin Zhang, Xinying Su,

Clinical Cancer Research

2012

155

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer

Robert H. Bradbury, David Acton, Nicola Broadbent,

Bioorganic & Medicinal Chemistry Letters

2013

51

Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression

Peter R. Holden, Neil H. James, A. Nigel Brooks,

Journal of Biochemical and Molecular Toxicology

2000

34

An open label phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.

Johann S. de Bono, Elena Cojocaru, Elizabeth Ruth Plummer,

Journal of Clinical Oncology

2019

14

Modulation of Arginine Vasopressin Secretion from Cultured Ovine Hypothalamic Cells by Glucocorticoids and Opioid Peptides

Ian Currie, Glenda Gillies, A. Nigel Brooks

Neuroendocrinology

1994

12

Page 1